Medpace Holdings, Inc. (MEDP) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Cincinnati, OH, United States. Der aktuelle CEO ist August James Troendle.
MEDP hat IPO-Datum 2016-08-11, 5,900 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $14.85B.
Medpace Holdings, Inc. is a clinical research organization that provides comprehensive drug and medical device development services to pharmaceutical, biotechnology, and medical device companies across North America, Europe, and Asia. The company supports the entire clinical development lifecycle from Phase I through Phase IV trials, offering specialized services including clinical monitoring, regulatory affairs, data management, pharmacovigilance, and post-marketing support across multiple therapeutic areas. Medpace also provides specialized laboratory services including bio-analytical testing, clinical human pharmacology, imaging services, and electrocardiography support. Founded in 1992 and headquartered in Cincinnati, Ohio, the company serves as a trusted partner in advancing new drug and device candidates toward regulatory approval.
